{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T12:02:58Z","timestamp":1792324978432,"version":"4.4.0"},"reference-count":84,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Neurol Neurosurg Psychiatry"],"accepted":{"date-parts":[[2025,5,15]]},"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>Aquaporin-4-positive neuromyelitis optica spectrum disorder (AQP4+NMOSD) is an autoimmune astrocytopathy primarily characterised by visual, motor, and sensory symptoms, depending on lesion location. However, patients frequently experience invisible symptoms such as fatigue, pain, neuropsychiatric symptoms, and bladder\/bowel dysfunction, which are often overlooked despite their substantial impact on quality of life. A systematic literature review was conducted using PubMed, with keywords related to fatigue, pain, bladder\/bowel dysfunction, and neuropsychiatric symptoms in the context of AQP4+NMOSD. The review explores the prevalence, assessment, and management of these frequently neglected symptoms. There is a critical need for improved detection and monitoring of invisible symptoms in AQP4+NMOSD. Enhanced assessment is crucial not only for developing targeted therapies but also for determining whether these symptoms reflect underlying disease activity, ultimately leading to optimised treatment strategies.<\/jats:p>","DOI":"10.1136\/jnnp-2025-336041","type":"journal-article","created":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T04:45:24Z","timestamp":1749703524000},"page":"744-752","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Silent burden: recognising and managing invisible symptoms in neuromyelitis optica"],"prefix":"10.1136","volume":"96","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2050-2908","authenticated-orcid":false,"given":"Lorena","family":"Lorefice","sequence":"first","affiliation":[{"name":"Multiple Sclerosis Center, ASL Cagliari, Binaghi Hospital, Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1574-9693","authenticated-orcid":false,"given":"Antonio","family":"Carotenuto","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0198-0488","authenticated-orcid":false,"given":"Giuseppe","family":"Fenu","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, ARNAS G. Brotzu, Cagliari, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"2025071606150564000_96.8.744.1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582-024-01014-1"},{"key":"2025071606150564000_96.8.744.2","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1212\/CON.0000000000001454","article-title":"NMOSD and MOGAD","volume":"30","author":"Sechi","year":"2024","journal-title":"Continuum (Minneap Minn)"},{"key":"2025071606150564000_96.8.744.3","doi-asserted-by":"publisher","DOI":"10.1097\/wco.0000000000000694"},{"key":"2025071606150564000_96.8.744.4","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awf151"},{"key":"2025071606150564000_96.8.744.5","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001729"},{"key":"2025071606150564000_96.8.744.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(18)30460-5"},{"key":"2025071606150564000_96.8.744.7","doi-asserted-by":"publisher","DOI":"10.1177\/1352458510376640"},{"key":"2025071606150564000_96.8.744.8","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.63.7.964"},{"key":"2025071606150564000_96.8.744.9","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000210137","article-title":"Quantitative Contribution of Clinical Attacks to Residual Disability in Patients With AQP4-Antibody Neuromyelitis Optica Spectrum Disorder","volume":"104","author":"Chen","year":"2025","journal-title":"Neurology (ECronicon)"},{"key":"2025071606150564000_96.8.744.10","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105093","article-title":"Progression independent of relapses in aquaporin4-IgG-seropositive neuromyelitis optica spectrum disorder, myelin oligodendrocyte glycoprotein antibody-associated disease, and multiple sclerosis","volume":"80","author":"Molazadeh","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"2025071606150564000_96.8.744.11","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105559","article-title":"Brain and spinal cord atrophy in NMOSD and MOGAD: Current evidence and future perspectives","volume":"85","author":"Lorefice","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"2025071606150564000_96.8.744.12","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105843","article-title":"Relapse-Independent disease activity in neuromyelitis optica spectrum disorder: A systematic review","volume":"90","author":"Etemadifar","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"2025071606150564000_96.8.744.13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/acn3.51008","article-title":"Factors associated with fatigue in CNS inflammatory diseases with AQP4 and MOG antibodies","volume":"7","author":"Yeo","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"2025071606150564000_96.8.744.14","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12411"},{"key":"2025071606150564000_96.8.744.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2015.05.007"},{"key":"2025071606150564000_96.8.744.16","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2014.775"},{"key":"2025071606150564000_96.8.744.17","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2018-320050"},{"key":"2025071606150564000_96.8.744.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224419","article-title":"Difference in fatigue and pain between neuromyelitis optica spectrum disorder and multiple sclerosis","volume":"15","author":"Masuda","year":"2020","journal-title":"PLoS ONE"},{"key":"2025071606150564000_96.8.744.19","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcad107","article-title":"Shared imaging markers of fatigue across multiple sclerosis, aquaporin-4 antibody neuromyelitis optica spectrum disorder and MOG antibody disease","volume":"5","author":"Camera","year":"2023","journal-title":"Brain Commun"},{"key":"2025071606150564000_96.8.744.20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0177230","article-title":"Fatigue in patients with neuromyelitis optica spectrum disorder and its impact on quality of life","volume":"12","author":"Seok","year":"2017","journal-title":"PLoS One"},{"key":"2025071606150564000_96.8.744.21","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102576","article-title":"Tired of not knowing what that fatigue score means? Normative data of the Modified Fatigue Impact Scale (MFIS)","volume":"46","author":"Strober","year":"2020","journal-title":"Mult Scler Relat Disord"},{"key":"2025071606150564000_96.8.744.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.11.041"},{"key":"2025071606150564000_96.8.744.23","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1988.00520280085020"},{"key":"2025071606150564000_96.8.744.24","doi-asserted-by":"publisher","DOI":"10.1191\/1352458502ms839oa"},{"key":"2025071606150564000_96.8.744.25","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2021-019"},{"key":"2025071606150564000_96.8.744.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2018.04.009"},{"key":"2025071606150564000_96.8.744.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2016.02.011"},{"key":"2025071606150564000_96.8.744.28","article-title":"Exercise therapy for fatigue in multiple sclerosis","volume":"2015","author":"Heine","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"2025071606150564000_96.8.744.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.07.042"},{"key":"2025071606150564000_96.8.744.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-021-10783-4"},{"key":"2025071606150564000_96.8.744.31","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.00778","article-title":"Pain in NMOSD and MOGAD: A Systematic Literature Review of Pathophysiology, Symptoms, and Current Treatment Strategies","volume":"11","author":"Asseyer","year":"2020","journal-title":"Front Neurol"},{"key":"2025071606150564000_96.8.744.32","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104192"},{"key":"2025071606150564000_96.8.744.33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071500","article-title":"The major brain endocannabinoid 2-AG controls neuropathic pain and mechanical hyperalgesia in patients with neuromyelitis optica","volume":"8","author":"Pellkofer","year":"2013","journal-title":"PLoS One"},{"key":"2025071606150564000_96.8.744.34","doi-asserted-by":"publisher","DOI":"10.1177\/1352458514522103"},{"key":"2025071606150564000_96.8.744.35","doi-asserted-by":"crossref","DOI":"10.1038\/srep18534","article-title":"Association of pain and CNS structural changes after spinal cord injury","volume":"6","author":"Jutzeler","year":"2016","journal-title":"Sci Rep"},{"key":"2025071606150564000_96.8.744.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2014.11.006"},{"key":"2025071606150564000_96.8.744.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.103048"},{"key":"2025071606150564000_96.8.744.38","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2024.1308498","article-title":"Regional spinal cord volumes and pain profiles in AQP4-IgG\u2009+\u2009NMOSD and MOGAD","volume":"15","author":"Asseyer","year":"2024","journal-title":"Front Neurol"},{"key":"2025071606150564000_96.8.744.39","doi-asserted-by":"publisher","DOI":"10.1177\/13524585241275491"},{"key":"2025071606150564000_96.8.744.40","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2012.768"},{"key":"2025071606150564000_96.8.744.41","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000985","article-title":"Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive Patients","volume":"8","author":"Ayzenberg","year":"2021","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"2025071606150564000_96.8.744.42","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2022.104213","article-title":"Factors correlated with neuropathic pain in patients with neuromyelitis optica spectrum disorder","volume":"68","author":"Zhang","year":"2022","journal-title":"Mult Scler Relat Disord"},{"key":"2025071606150564000_96.8.744.43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2021.117546","article-title":"Patient-reported burden of symptoms in neuromyelitis optica: A secondary analysis on pain and quality of life","volume":"428","author":"Fujihara","year":"2021","journal-title":"J Neurol Sci"},{"key":"2025071606150564000_96.8.744.44","first-page":"129","article-title":"Pain assessment: global use of the Brief Pain Inventory","volume":"23","author":"Cleeland","year":"1994","journal-title":"Ann Acad Med Singap"},{"key":"2025071606150564000_96.8.744.45","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(87)91074-8"},{"key":"2025071606150564000_96.8.744.46","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2004.12.010"},{"key":"2025071606150564000_96.8.744.47","doi-asserted-by":"publisher","DOI":"10.1185\/030079906X132488"},{"key":"2025071606150564000_96.8.744.48","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmn.2019.03.003"},{"key":"2025071606150564000_96.8.744.49","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2020.1749259"},{"key":"2025071606150564000_96.8.744.50","doi-asserted-by":"publisher","DOI":"10.5213\/inj.2040346.173"},{"key":"2025071606150564000_96.8.744.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2015.07.015"},{"key":"2025071606150564000_96.8.744.52","doi-asserted-by":"publisher","DOI":"10.1055\/s-0040-1701557"},{"key":"2025071606150564000_96.8.744.53","doi-asserted-by":"publisher","DOI":"10.1111\/cen3.12279"},{"key":"2025071606150564000_96.8.744.54","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2012-049"},{"key":"2025071606150564000_96.8.744.55","doi-asserted-by":"publisher","DOI":"10.1038\/sj.sc.3101887"},{"key":"2025071606150564000_96.8.744.56","doi-asserted-by":"publisher","DOI":"10.3109\/09638288.2015.1027007"},{"key":"2025071606150564000_96.8.744.57","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105596","article-title":"Cognitive and psychopathological features of neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease: A narrative review","volume":"85","author":"Kazzi","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"2025071606150564000_96.8.744.58","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2021.102757"},{"key":"2025071606150564000_96.8.744.59","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1842","article-title":"Cognitive impairment in NMOSD-More questions than answers","volume":"10","author":"Czarnecka","year":"2020","journal-title":"Brain Behav"},{"key":"2025071606150564000_96.8.744.60","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2017.07.014"},{"key":"2025071606150564000_96.8.744.61","doi-asserted-by":"crossref","DOI":"10.3390\/jpm12050743","article-title":"Cognitive Performance and Health-Related Quality of Life in Patients with Neuromyelitis Optica Spectrum Disorder","volume":"12","author":"Lopez-Soley","year":"2022","journal-title":"J Pers Med"},{"key":"2025071606150564000_96.8.744.62","doi-asserted-by":"publisher","DOI":"10.1177\/1352458515576982"},{"key":"2025071606150564000_96.8.744.63","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A4403"},{"key":"2025071606150564000_96.8.744.64","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104492"},{"key":"2025071606150564000_96.8.744.65","doi-asserted-by":"publisher","DOI":"10.1177\/13524585231151212"},{"key":"2025071606150564000_96.8.744.66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-08889-9"},{"key":"2025071606150564000_96.8.744.67","doi-asserted-by":"publisher","DOI":"10.1002\/ana.23721"},{"key":"2025071606150564000_96.8.744.68","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002067"},{"key":"2025071606150564000_96.8.744.69","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0033878","article-title":"White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica","volume":"7","author":"Blanc","year":"2012","journal-title":"PLoS One"},{"key":"2025071606150564000_96.8.744.70","doi-asserted-by":"publisher","DOI":"10.1111\/ene.13224"},{"key":"2025071606150564000_96.8.744.71","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15073"},{"key":"2025071606150564000_96.8.744.72","first-page":"49","article-title":"Cognitive function and brain magnetic resonance imaging profiles in neuromyelitis optica spectrum disorder and multiple sclerosis","volume":"29","author":"Ashtari","year":"2024","journal-title":"J Res Med Sci"},{"key":"2025071606150564000_96.8.744.73","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2024.105612"},{"key":"2025071606150564000_96.8.744.74","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2019.00608","article-title":"Cognitive Impairment in Neuromyelitis Optica Spectrum Disorders: A Review of Clinical and Neuroradiological Features","volume":"10","author":"Oertel","year":"2019","journal-title":"Front Neurol"},{"key":"2025071606150564000_96.8.744.75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-71176-x"},{"key":"2025071606150564000_96.8.744.76","doi-asserted-by":"publisher","DOI":"10.1080\/23279095.2023.2210242"},{"key":"2025071606150564000_96.8.744.77","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105007","article-title":"The prevalence of depression, anxiety, and sleep disturbances in patients with neuromyelitis optica spectrum disorders (NMOSD): A systematic review and meta-analysis","volume":"79","author":"Liu","year":"2023","journal-title":"Mult Scler Relat Disord"},{"key":"2025071606150564000_96.8.744.78","first-page":"e1","article-title":"Treatment-Resistant Depression and Aquaporin-4 Autoantibodies: Is There a Link?","volume":"78","author":"Iorio","year":"2015","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"2025071606150564000_96.8.744.79","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105775","article-title":"The burden of psychiatric morbidity in Multiple Sclerosis, AQP4-antibody NMOSD and MOGAD before and after neurological diagnosis","volume":"89","author":"Tan","year":"2024","journal-title":"Mult Scler Relat Disord"},{"key":"2025071606150564000_96.8.744.80","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12267"},{"key":"2025071606150564000_96.8.744.81","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2015.11.031"},{"key":"2025071606150564000_96.8.744.82","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-022-02757-4"},{"key":"2025071606150564000_96.8.744.83","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-022-00356-6"},{"key":"2025071606150564000_96.8.744.84","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102394","article-title":"Harmonization of real-world studies in multiple sclerosis: Retrospective analysis from the rirems group","volume":"45","author":"Moccia","year":"2020","journal-title":"Mult Scler Relat Disord"}],"container-title":["Journal of Neurology, Neurosurgery &amp; Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnnp-2025-336041","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T13:15:17Z","timestamp":1752671717000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnnp.bmj.com\/lookup\/doi\/10.1136\/jnnp-2025-336041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":84,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2025,7,16]]},"published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1136\/jnnp-2025-336041"],"URL":"https:\/\/doi.org\/10.1136\/jnnp-2025-336041","relation":{},"ISSN":["0022-3050","1468-330X"],"issn-type":[{"value":"0022-3050","type":"print"},{"value":"1468-330X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,12]]}}}